Variables clínicas asociadas a mortalidad en pacientes con COVID-19


La descarga de datos todavía no está disponible.


World Health Organization (WHO). WHODirector-General’s opening remarks at the media briefing on COVID-19-11 March 2020. Ginebra: WHO; 2020. [citado 2020 May 30]. Disponible en:

Aydemir D, Ulusu NN. Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic. Biotechnol App Biochem. 2020.

Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-6.

Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID?19 infection. Am J Hematol. 2020;95(6):E131-4.

Zhang L, Yan X, Fan Q, Liu H, Liu X Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid19. J Thromb Haemost. 2020;18(6):1324-9

Ferrnari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem LabMed. 2020;58(7):1095-9.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052?9.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8.

Cómo citar
Guzmán Sáenz RC, Sáenz López JD, Tatis Villamizar KE. Variables clínicas asociadas a mortalidad en pacientes con COVID-19. Rev. Colomb. Nefrol. [Internet]. 3 de junio de 2020 [citado 27 de septiembre de 2020];7(Supl.2). Disponible en: